Enquiry Sample

Transcriptomics Market Value to reach 8.9 Billion USD by 2025 Globally

Transcriptomics Market Value to reach 8.9 Billion USD by 2025 Globally

May 2019 | ICT Media

Transcriptomics Market Research Reports Overview:

Transcriptomics Market by Technology (Microarray, Real Time-PCR (qPCR), Sequencing) Product & Services (Instruments, Consumables, Software, Services) End User (Pharmaceutical & Biotechnology Companies, Government Institutes & Academic Centers, Contract research Organizations (CROs)) - Global Industry Analysis & Forecast to 2025

Industry Outlook and Trend Analysis

The Transcriptomics Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Transcriptomics is the investigation of whole arrangement of RNA transcripts created by the genome of any living being. Developing progressions in the field of transcriptomics, for example, broad utilization of RNA-sequencing and ascend in use of transcriptomics, which incorporates medicate revelation is anticipated to drive the development of the transcriptomics market.

Drivers and Restraints

Increment in mechanical progressions and ascend in research allows by different foundations is anticipated to drive the market development. Moreover, the capability of RNAs to go about as contender for analytic biomarkers and indicators of medication reaction are foreseen to additionally drive the interest for transcriptomics all inclusive. Nonetheless, institutionalization worries over RNA sequencing and absence of talented experts confine the market development.

Regional Insights

North America represented the share of over 45% of the general market in 2016 and is anticipated to keep up its predominance all through the conjecture time frame.

By Region

North America
Rest of Europe
South Korea
Southeast Asia
Rest of Asia-Pacific
South America
Rest of South America
Middle East and Africa
Saudi Arabia
South Africa
Rest of MEA
Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Thermo Fisher Scientific Inc.
Agilent Technologies
Merck & Co., Inc.
QIAGEN (Exiqon)
Promega Corporation
Fluidigm Corporation
GE Healthcare Dharmacon Inc.
Bio-Rad Laboratories, Inc.
Illumina, Inc.
F. Hoffmann-La Roche Ltd.
Some of the key questions answered by the report are:

What was the market size in 2014 and forecast from 2015 to 2025?
What will be the industry market growth from 2015 to 2025?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?Market Classification

· Transcriptomics Market, By Product, Estimates and Forecast, 2014-2025 ($Million)

o Instruments

o Consumables

o Software

o Services

· Transcriptomics Market, By Technology, Estimates and Forecast, 2014-2025 ($Million)

o Microarray

o Real Time-PCR (qPCR)

o Sequencing

· Transcriptomics Market, By End User, Estimates and Forecast, 2014-2025 ($Million)

o Contract research Organizations (CROs)

o Government Institutes & Academic Centers

o Pharmaceutical & Biotechnology Companies

Get More Information : https://www.planetmarketreports.com/reports/transcriptomics-market-by-technology-product-and-services-and-end-user-global-industry-analysis-and-forecast-to-2025